- ホーム
- > 洋書
- > 英文書
- > Science / Mathematics
Full Description
This book provides concepts, procedures, guidelines, and regulatory affairs in the drug development. It begins with a detailed overview of the drug development lifecycle, from initial discovery and preclinical research to clinical trials and market approval, addressing scientific, regulatory, and ethical considerations at each stage. The book covers the evolution of global trade agreements like GATT and the WTO's impact on pharmaceuticals, highlighting issues surrounding pharmaceutical patents and intellectual property rights. It discusses the importance of the SUPAC guidelines in ensuring quality and consistency in drug manufacturing post-approval and examines the WHO's guidelines on technology development and transfer. The fundamentals of regulatory affairs are covered, emphasizing the roles and responsibilities of regulatory professionals. The book provides an in-depth look at regulatory frameworks of major agencies worldwide, including the CDSCO in India, the FDA in the U.S., the EMA in the EU, the TGA in Australia, the PMDA in Japan, Health Canada, and regulatory authorities in emerging markets. It also addresses the international regulatory landscape for medical devices and reviews foundational pharmaceutical regulations. Additionally, it explores regulatory guidelines for clinical testing, including the roles and responsibilities under pharmaceutical legislation, principles of bioethics and biosafety, the digital transformation in clinical trials, and the critical role of pharmacovigilance. The book concludes with an examination of the global regulatory scenario for pharmaceutical excipients, providing a detailed roadmap through the complexities of drug development, regulatory compliance, and global standards. This book is valuable for professionals, researchers, and students of pharmaceutical sciences.
Contents
Chapter1. Stages and Processes in Drug Development and Discovery. Chapter 2. The WTO and its Impact on Pharmaceuticals. Chapter 4. Pharmaceutical Patents and IPR. Chapter 5. Understanding the Scale-Up and Post-Approval Changes (SUPAC) Guidelines. Chapter 6. WHO Guidelines on Technology Development & Transfer. Chapter 7. Fundamentals of Regulatory Affairs in Pharmaceuticals. Chapter 8. Regulatory Framework of the Central Drugs Standard Control Organization (CDSCO) in India. Chapter 9. Regulatory Overview of the U.S Food and Drug Administration (FDA). Chapter 10. Regulatory Framework of the European Medicines Agency (EMA) and EU Member States. Chapter 11. Regulatory Processes of the Therapeutic Good Administration (TGA) in Australia. Chapter 12. Regulatory Landscape of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. Chapter 13. Health Canada's Regulatory Framework for Pharmacueticals. Chapter 14. Regulatory Sciences in Emerging Markets of Rest of The World (Row). Chapter 15. International Regulatory Authorities for Medical Devices. Chapter 16. Regulatory Overview: Indian Drugs and Cosmetics Act of 1940 and Rules of 1945. Chapter 17. Responsibilities and Functions Under Pharmaceutical Legislation. Chapter 18. Principles of Bioethics and Biosafety in Pharmaceuticals. Chapter 19. Digital Transformation in Clinical Trials and Research. Chapter 20. Pharmacovigilance: Ensuring safety in clinical trials. Chapter 21. Regulatory Scenario of Excipients Worldwide. Chapter 22. Innovation through Renovation: Navigating Regulatory Framework and Technical Challenges of Drug Repositioning.
